Bioequivalence of Bicalutamide New Formulation in Japan
Clinical trial NCT01416870 · TERMINATED
Trial details
- NCT number
- NCT01416870
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-11-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.